Sequence Bio is a Canadian genomics and precision medicine company built around the founder population of Newfoundland and Labrador. Public materials describe a systems biology approach that combines population genomics, multi-omics, real-world data, and deeply characterized phenotypes to identify and validate novel drug targets. The company works at the interface of genomics discovery, target discovery, and translational medicine partnerships.